Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 01:21:08 UTC |
---|
Update Date | 2021-09-26 22:58:20 UTC |
---|
HMDB ID | HMDB0248182 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Aloxistatin |
---|
Description | Aloxistatin, also known as E64D inhibitor, belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review a small amount of articles have been published on Aloxistatin. This compound has been identified in human blood as reported by (PMID: 31557052 ). Aloxistatin is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Aloxistatin is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NCCC(C)C InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21) |
---|
Synonyms | Value | Source |
---|
Ethyl 3-({4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylic acid | HMDB | Epoxysuccinyl-leucylamide(3-methyl)butane ethyl ester | HMDB | (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester | HMDB | Protease inhibitor e64d | HMDB | Loxistatin | HMDB | Ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate | HMDB | e64d Inhibitor | HMDB | Loxistatin, (2S-(2alpha,3beta(r*)))-isomer | HMDB | Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate | HMDB | Ethyl epoxysuccinyl-leucylamido-3-methylbutane | HMDB | Aloxistatin | MeSH |
|
---|
Chemical Formula | C17H30N2O5 |
---|
Average Molecular Weight | 342.436 |
---|
Monoisotopic Molecular Weight | 342.215472074 |
---|
IUPAC Name | ethyl 3-({3-methyl-1-[(3-methylbutyl)carbamoyl]butyl}carbamoyl)oxirane-2-carboxylate |
---|
Traditional Name | ethyl 3-({3-methyl-1-[(3-methylbutyl)carbamoyl]butyl}carbamoyl)oxirane-2-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NCCC(C)C |
---|
InChI Identifier | InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21) |
---|
InChI Key | SRVFFFJZQVENJC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Leucine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Leucine or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Oxirane carboxylic acid
- Oxirane carboxylic acid or derivatives
- Carboxamide group
- Carboxylic acid ester
- Secondary carboxylic acid amide
- Dialkyl ether
- Oxirane
- Ether
- Monocarboxylic acid or derivatives
- Oxacycle
- Organoheterocyclic compound
- Organic oxide
- Carbonyl group
- Organic nitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Aloxistatin,1TMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)NCCC(C)C)[Si](C)(C)C | 2300.9 | Semi standard non polar | 33892256 | Aloxistatin,1TMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)NCCC(C)C)[Si](C)(C)C | 2277.7 | Standard non polar | 33892256 | Aloxistatin,1TMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)NCCC(C)C)[Si](C)(C)C | 3017.6 | Standard polar | 33892256 | Aloxistatin,1TMS,isomer #2 | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C | 2353.7 | Semi standard non polar | 33892256 | Aloxistatin,1TMS,isomer #2 | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C | 2280.5 | Standard non polar | 33892256 | Aloxistatin,1TMS,isomer #2 | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C | 3085.9 | Standard polar | 33892256 | Aloxistatin,2TMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C)[Si](C)(C)C | 2297.5 | Semi standard non polar | 33892256 | Aloxistatin,2TMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C)[Si](C)(C)C | 2366.4 | Standard non polar | 33892256 | Aloxistatin,2TMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C)[Si](C)(C)C | 2777.0 | Standard polar | 33892256 | Aloxistatin,1TBDMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)NCCC(C)C)[Si](C)(C)C(C)(C)C | 2543.0 | Semi standard non polar | 33892256 | Aloxistatin,1TBDMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)NCCC(C)C)[Si](C)(C)C(C)(C)C | 2452.9 | Standard non polar | 33892256 | Aloxistatin,1TBDMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)NCCC(C)C)[Si](C)(C)C(C)(C)C | 3081.8 | Standard polar | 33892256 | Aloxistatin,1TBDMS,isomer #2 | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C(C)(C)C | 2581.5 | Semi standard non polar | 33892256 | Aloxistatin,1TBDMS,isomer #2 | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C(C)(C)C | 2455.5 | Standard non polar | 33892256 | Aloxistatin,1TBDMS,isomer #2 | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C(C)(C)C | 3141.0 | Standard polar | 33892256 | Aloxistatin,2TBDMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2796.7 | Semi standard non polar | 33892256 | Aloxistatin,2TBDMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2723.2 | Standard non polar | 33892256 | Aloxistatin,2TBDMS,isomer #1 | CCOC(=O)C1OC1C(=O)N(C(CC(C)C)C(=O)N(CCC(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2992.6 | Standard polar | 33892256 |
| Show more...
---|